507 related articles for article (PubMed ID: 15533319)
1. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice.
Li J; Henman MC; Doyle KM; Strbian D; Kirby BP; Tatlisumak T; Shaw GG
Brain Res; 2004 Dec; 1029(1):84-92. PubMed ID: 15533319
[TBL] [Abstract][Full Text] [Related]
2. The pre-ischaemic neuroprotective effects of N1-dansyl-spermine in a transient focal cerebral ischaemia model in mice.
Li J; Henman MC; Tatlisumak T; Shaw GG; Doyle KM
Brain Res; 2005 Sep; 1055(1-2):180-5. PubMed ID: 16095573
[TBL] [Abstract][Full Text] [Related]
3. The neuroprotective effects of N1-dansyl-spermine in the gerbil model of cerebral ischaemia.
Kirby BP; Shaw GG
Brain Res; 2004 Jun; 1011(1):74-83. PubMed ID: 15140646
[TBL] [Abstract][Full Text] [Related]
4. The pre-ischaemic neuroprotective effects of the polyamine analogues BU43b and BU36b in permanent and transient focal cerebral ischaemia models in mice.
Li J; Henman MC; Atkinson J; Fixon-Owoo S; Tatlisumak T; Shaw GG; Doyle KM
Brain Res; 2006 Mar; 1076(1):209-15. PubMed ID: 16473330
[TBL] [Abstract][Full Text] [Related]
5. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
6. Effect of spermine and N1-dansyl-spermine on epileptiform activity in mouse cortical slices.
Kirby BP; Shaw GG
Eur J Pharmacol; 2005 Nov; 524(1-3):53-9. PubMed ID: 16253230
[TBL] [Abstract][Full Text] [Related]
7. N1-dansyl-spermine: a potent polyamine antagonist.
Kirby BP; Ryder SA; Seiler N; Renault J; Shaw GG
Brain Res; 2004 Jun; 1011(1):69-73. PubMed ID: 15140645
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
Masuko T; Namiki R; Nemoto Y; Miyake M; Kizawa Y; Suzuki T; Kashiwagi K; Igarashi K; Kusama T
J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist.
Gill R; Alanine A; Bourson A; Buttelmann B; Fischer G; Heitz MP; Kew JN; Levet-Trafit B; Lorez HP; Malherbe P; Miss MT; Mutel V; Pinard E; Roever S; Schmitt M; Trube G; Wybrecht R; Wyler R; Kemp JA
J Pharmacol Exp Ther; 2002 Sep; 302(3):940-8. PubMed ID: 12183650
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats.
Allahtavakoli M; Shabanzadeh A; Roohbakhsh A; Pourshanazari A
Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):309-14. PubMed ID: 17910613
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of NMDA receptor glycine recognition site antagonism persists when brain temperature is controlled.
Takaoka S; Bart RD; Pearlstein R; Brinkhous A; Warner DS
J Cereb Blood Flow Metab; 1997 Feb; 17(2):161-7. PubMed ID: 9040495
[TBL] [Abstract][Full Text] [Related]
12. NMDA receptor blockade fails to alter axonal injury in focal cerebral ischemia.
Yam PS; Dunn LT; Graham DI; Dewar D; McCulloch J
J Cereb Blood Flow Metab; 2000 May; 20(5):772-9. PubMed ID: 10826527
[TBL] [Abstract][Full Text] [Related]
13. The competitive NMDA receptor antagonist CGP 40116 is a potent neuroprotectant in a rat model of focal cerebral ischemia.
Sauer D; Allegrini PR; Fagg GE
J Neural Transm Suppl; 1994; 43():81-9. PubMed ID: 7884410
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection (focal ischemia) and neurotoxicity (electroencephalographic) studies in rats with AHN649, a 3-amino analog of dextromethorphan and low-affinity N-methyl-D-aspartate antagonist.
Tortella FC; Britton P; Williams A; Lu XC; Newman AH
J Pharmacol Exp Ther; 1999 Oct; 291(1):399-408. PubMed ID: 10490930
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of L-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils.
Gigler G; Szénási G; Simó A; Lévay G; Hársing LG; Sas K; Vécsei L; Toldi J
Eur J Pharmacol; 2007 Jun; 564(1-3):116-22. PubMed ID: 17407777
[TBL] [Abstract][Full Text] [Related]
16. The protective effect of MK-801 on infarct development over a period of 24 h as assessed by diffusion-weighted magnetic resonance imaging.
Gill R; Sibson NR; Maskell L; Carpenter TA; Hall LD; Pickard JD
NMR Biomed; 1996 Sep; 9(6):241-8. PubMed ID: 9073302
[TBL] [Abstract][Full Text] [Related]
17. The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats.
Katsuta K; Nakanishi H; Shirakawa K; Yoshida K; Takagi K; Tamura A
J Cereb Blood Flow Metab; 1995 Mar; 15(2):345-8. PubMed ID: 7860668
[TBL] [Abstract][Full Text] [Related]
18. -(S)-Alpha-phenyl-2-pyridine-ethanamine Dihydrochloride-, a low affinity uncompetitive N-methyl-D-aspartic acid antagonist, is effective in rodent models of global and focal ischemia.
Cregan EF; Peeling J; Corbett D; Buchan AM; Saunders J; Auer RN; Gao M; Mccarthy DJ; Eisman MS; Campbell TM; Murray RJ; Stagnitto ML; Palmer GC
J Pharmacol Exp Ther; 1997 Dec; 283(3):1412-24. PubMed ID: 9400017
[TBL] [Abstract][Full Text] [Related]
19. [Protective effect of dl-3-n-butylphthalide on ischemic neurological damage and abnormal behavior in rats subjected to focal ischemia].
Liu XG; Feng YP
Yao Xue Xue Bao; 1995 Dec; 30(12):896-903. PubMed ID: 8712015
[TBL] [Abstract][Full Text] [Related]
20. The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia.
Gill R
Cerebrovasc Brain Metab Rev; 1994; 6(3):225-56. PubMed ID: 7529037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
